Testing a cancer drug placed right into the tumor in people with DMG
Original title: Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early test in people to find a safe dose.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
Doctors are testing a cancer drug put straight into a brain tumor called DMG.
Who this trial is for. This trial is for people with a brain tumor called DMG, including DIPG. It tests a drug, LSAM-Cisplatin, given right into the tumor during surgery.
Where it stands. This trial has not reported results. It is testing different doses of the drug. It is also looking at how tumors respond. Those answers are not in yet.
What this means, and what it doesn't
What it could mean: Doctors want to learn if this way of giving the drug is safe. If this sounds like your situation, you can ask your care team about it. They can talk with you about whether a trial makes sense.
What it doesn't mean: This does not mean the drug works. A trial is a test, not proven care. Joining one is not a promise that it will help you. It is not a cure.
Source: ClinicalTrials.gov, August 17, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.